Table of Contents Author Guidelines Submit a Manuscript
Critical Care Research and Practice
Volume 2011 (2011), Article ID 313854, 10 pages
http://dx.doi.org/10.1155/2011/313854
Clinical Study

Thromboelastography to Monitor Clotting/Bleeding Complications in Patients Treated with the Molecular Adsorbent Recirculating System

1Medical Intensive Care Unit, University Hospital Zurich, 8091 Zurich, Switzerland
2Clinic of Internal Medicine, Hospital Uster, 8610 Uster, Switzerland
3Division of Haematology, University Hospital Zurich, 8091 Zurich, Switzerland
4Surgical Intensive Care Unit, University Hospital Zurich, HOF-B-110, Raemistraße 100, 8091 Zurich, Switzerland
5Division of Gastroenterology and Hepatology, University Hospital Zurich, 8091 Zurich, Switzerland
6Multiorgan Transplant Program, University Health Network, University of Toronto, Toronto, ON M5G 2N2, Canada

Received 10 November 2010; Accepted 13 January 2011

Academic Editor: Ali A. El Solh

Copyright © 2011 Esther B. Bachli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Eghtesad, A. B. Jain, and J. J. Fung, “Living donor liver transplantation: ethics and safety,” Transplantation Proceedings, vol. 35, no. 1, pp. 51–52, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. H. E. Wasmuth, D. Kunz, E. Yagmur et al., “Patients with acute on chronic liver failure display 'sepsis-like' immune paralysis,” Journal of Hepatology, vol. 42, no. 2, pp. 195–201, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Phua and K. H. Lee, “Liver support devices,” Current Opinion in Critical Care, vol. 14, no. 2, pp. 208–215, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Mullhaupt, G. A. Kullak-Ublick, P. Ambühl et al., “First clinical experience with Molecular Adsorbent Recirculating System (MARS) in six patients with severe acute on chronic liver failure,” Liver, vol. 22, no. 2, pp. 59–62, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. S. Khuroo, M. S. Khuroo, and K. L. C. Farahat, “Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis,” Liver Transplantation, vol. 10, no. 9, pp. 1099–1106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. C. Reverter, “Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? Yes,” Journal of Thrombosis and Haemostasis, vol. 4, no. 4, pp. 717–720, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Davenport, “The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit,” American Journal of Kidney Diseases, vol. 30, no. 5, pp. S20–S27, 1997. View at Google Scholar · View at Scopus
  8. E. B. Bachli, R. A. Schuepbach, M. Maggiorini, R. Stocker, B. Müllhaupt, and E. L. Renner, “Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications,” Liver International, vol. 27, no. 4, pp. 475–484, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Doria, L. Mandalà, J. D. Smith et al., “Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system,” Clinical Transplantation, vol. 18, no. 4, pp. 365–371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Faybik, A. Bacher, S. A. Kozek-Langenecker et al., “Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study,” Critical Care, vol. 10, no. 1, article R24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. H. G. D. Hendriks, K. Meijer, J. T. M. de Wolf et al., “Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation,” Blood Coagulation and Fibrinolysis, vol. 13, no. 4, pp. 309–313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. C. G. Child and J. G. Turcotte, “Surgery and portal hypertension,” in The Liver and Portal Hypertension, C. G. Child III, Ed., p. 50, Saunders, Philadelphia, Pa, USA, 1964. View at Google Scholar
  13. P. S. Kamath, R. H. Wiesner, M. Malinchoc et al., “A model to predict survival in patients with end-stage liver disease,” Hepatology, vol. 33, no. 2, pp. 464–470, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. J. R. Le Gall, S. Lemeshow, and F. Saulnier, “A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study,” Journal of the American Medical Association, vol. 270, no. 24, pp. 2957–2963, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. H. C. Hemker, P. Giesen, R. Al Dieri et al., “Calibrated automated thrombin generation measurement in clotting plasma,” Pathophysiology of Haemostasis and Thrombosis, vol. 33, no. 1, pp. 4–15, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Davidson, J. F. Burman, S. M. Philips et al., “Correlation between thrombin potential and bleeding after cardiac surgery in adults,” Blood Coagulation and Fibrinolysis, vol. 14, no. 2, pp. 175–179, 2003. View at Publisher · View at Google Scholar
  17. U. Heemann, U. Treichel, J. Loock et al., “Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study,” Hepatology, vol. 36, no. 4, pp. 949–958, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. R. Mitzner, J. Stange, S. Klammt et al., “Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial,” Liver Transplantation, vol. 6, no. 3, pp. 277–286, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. L. E. Schmidt, L. P. Wang, B. A. Hansen, and F. S. Larsen, “Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial,” Liver Transplantation, vol. 9, no. 3, pp. 290–297, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. El Banayosy, L. Kizner, V. Schueler, S. Bergmeier, D. Cobaugh, and R. Koerfer, “First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock,” ASAIO Journal, vol. 50, no. 4, pp. 332–337, 2004. View at Google Scholar · View at Scopus
  21. P. Krisper, B. Haditsch, R. Stauber et al., “In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation,” Journal of Hepatology, vol. 43, no. 3, pp. 451–457, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Sen, N. A. Davies, R. P. Mookerjee et al., “Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study,” Liver Transplantation, vol. 10, no. 9, pp. 1109–1119, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Jalan, S. Sen, C. Steiner, D. Kapoor, A. Alisa, and R. Williams, “Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis,” Journal of Hepatology, vol. 38, no. 1, pp. 24–31, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Klammt, J. Stange, S. R. Mitzner, P. Peszynski, E. Peters, and S. Liebe, “Extracorporeal liver support by recirculating albumin dialysis: analysing the effect of the first clinically used generation of the MARSystem,” Liver, vol. 22, no. 2, pp. 30–34, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. S. R. Mitzner, S. Klammt, P. Peszynski et al., “Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the Molecular Adsorbent Recirculating System,” Therapeutic Apheresis, vol. 5, no. 5, pp. 417–422, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. L. E. Schmidt, V. R. Sorensen, L. B. Svendsen , F. S. Larsen, J. Stange, and B. A. Hansen, “Improvement of systemic vascular resistance and arterial pressure in patients with acute on chronic liver failure during treatment with the molecular adsorbent recycling system (MARS),” Hepatology, vol. 32, no. 4, p. 967, 2000. View at Google Scholar
  27. P. Evenepoel, P. Wilmer, F. Nevens et al., “Prometheus versus MARS: comparison of efficiency in two different liver detoxification devices,” Nephrology, Dialysis, Transplantation, vol. 20, p. V372, 2005. View at Google Scholar
  28. P. Sorkine, R. Ben Abraham, O. Szold et al., “Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure,” Critical Care Medicine, vol. 29, no. 7, pp. 1332–1336, 2001. View at Google Scholar · View at Scopus
  29. L. E. Schmidt, L. B. Svendsen, V. R. Sørensen, B. A. Hansen, and F. S. Larsen, “Cerebral blood flow velocity increases during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure,” Liver Transplantation, vol. 7, no. 8, pp. 709–712, 2001. View at Publisher · View at Google Scholar · View at Scopus